BM
Biomind Labs Inc.
BMNDF · OTC
$0.60 +139.71% (+$0.35)
Market Cap $19.4M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.5
16.7% downside
Current Price
$0.6
Undervalued Fair Value Overvalued
According to Bulios Fair Price, BMNDF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
-
N/A EV/FFO N/A
P/S N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
57 /100
Average ROA 4,170,810.00%
Asset turnover 0.00x
ROIC 128.74%
Debt
0 /100
High Int. coverage -27.18x
Current ratio 0.00x
Net debt/EBITDA N/A
Stability
35 /100
Moderate EPS volatility 22.83%
Profitable years 0
Beta 7.28x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BMNDF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Alejandro Antalich
Employees
5
Headquarters
Vancouver